Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|30|4392-4399

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.30, 2015-10, pp. : 4392-4399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome?

By Gloro Romain   Ducrotte Philippe   Reimund Jean-Marie  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1079-1095

Informa Healthcare

Access to resources Recommend Favorite

Targeting Antioxidants to Mitochondria: A Potential New Therapeutic Strategy for Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 13, Iss. 8, 2007-03 ,pp. : 845-863

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases

By Broadley K.J.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1669-1692

Informa Healthcare

Access to resources Recommend Favorite

Protease-Activated Receptors as Therapeutic Targets in Visceral Pain

By  

Current Neuropharmacology, Vol. 11, Iss. 6, 2013-12 ,pp. : 598-605

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite